These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8133573)
1. From the Food and Drug Administration. Nightingale SL JAMA; 1993 Dec; 270(22):2669. PubMed ID: 8133573 [No Abstract] [Full Text] [Related]
2. From the Food and Drug Administration. Nightingale SL JAMA; 1995 Jul; 274(4):292. PubMed ID: 7609246 [No Abstract] [Full Text] [Related]
3. From the Food and Drug Administration. Nightingale SL JAMA; 1990 Aug; 264(6):677. PubMed ID: 2197448 [No Abstract] [Full Text] [Related]
4. A new era in drug regulation? Dresser R Hastings Cent Rep; 2005; 35(3):10-1. PubMed ID: 16092391 [No Abstract] [Full Text] [Related]
5. Metformin for non-insulin-dependent diabetes mellitus. Med Lett Drugs Ther; 1995 May; 37(948):41-2. PubMed ID: 7739421 [No Abstract] [Full Text] [Related]
6. Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience. Lipska KJ; Flory JH; Hennessy S; Inzucchi SE Circulation; 2016 Nov; 134(18):1405-1408. PubMed ID: 27799258 [No Abstract] [Full Text] [Related]
7. FDA plans to continue cracking down on unapproved drugs. Lavine G Am J Health Syst Pharm; 2008 Sep; 65(17):1594. PubMed ID: 18714097 [No Abstract] [Full Text] [Related]
8. Rosiglitazone and implications for pharmacovigilance. Kazi D BMJ; 2007 Jun; 334(7606):1233-4. PubMed ID: 17569897 [TBL] [Abstract][Full Text] [Related]
9. Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin. Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA Arch Intern Med; 2011 Jun; 171(11):1042-3; author reply 1043. PubMed ID: 21670379 [No Abstract] [Full Text] [Related]
10. Effect of US Food and Drug Administration's Cardiovascular Safety Guidance on Diabetes Drug Development. Hwang TJ; Franklin JM; Kesselheim AS Clin Pharmacol Ther; 2017 Aug; 102(2):290-296. PubMed ID: 28390139 [TBL] [Abstract][Full Text] [Related]
11. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk. Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527 [No Abstract] [Full Text] [Related]
12. Assessing the cardiovascular safety of diabetes therapies. Goldfine AB N Engl J Med; 2008 Sep; 359(11):1092-5. PubMed ID: 18784098 [No Abstract] [Full Text] [Related]
13. FDA cracks down on labeling, initiates trial result reporting. Osborne R; Waltz E Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742 [No Abstract] [Full Text] [Related]
14. How the US drug safety system should be changed. Strom BL JAMA; 2006 May; 295(17):2072-5. PubMed ID: 16670415 [No Abstract] [Full Text] [Related]
15. The FDA Revises Restrictions on Metformin Use in Kidney Impairment. Aschenbrenner DS Am J Nurs; 2016 Aug; 116(8):22-3. PubMed ID: 27466921 [No Abstract] [Full Text] [Related]
17. Metformin therapy in patients with type 2 diabetes complicated by heart failure. Inzucchi SE; Masoudi FA; McGuire DK Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066 [No Abstract] [Full Text] [Related]
18. Randomized controlled trials and assessment of drug safety. Clark DW; Coulter DM; Besag FM Drug Saf; 2008; 31(12):1057-61. PubMed ID: 19026023 [No Abstract] [Full Text] [Related]
19. Drug safety and effectiveness in children. Guharoy R Am J Health Syst Pharm; 2002 Aug; 59(16):1569-70. PubMed ID: 12185835 [No Abstract] [Full Text] [Related]